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SUMMARY
Spontaneous preterm birth is a major public health problem, with a clear genetic component. 
Genetic association studies have evolved substantially in recent years, moving away from the 
traditional candidate gene analyses to newer approaches utilizing sophisticated analysis platforms 
to examine sequencing data, and shifting towards functional studies including methylation 
analysis. It is becoming increasingly evident that careful clinical phenotyping is crucial to high 
quality genetic association studies regardless of the assay or platform being used. Nonetheless, 
genetic studies of prematurity are hampered by numerous challenges including small sample sizes, 
incomplete phenotying, population stratification, and multiple comparisons. As the costs of 
sequencing and functional analyses continue to decrease, unbiased genome-wide assays will be 
more widely available. Researchers have met improved success recently when critically applying 
clinical phenotyping knowledge to group women prior to analyzing genotyping results. 
Eventually, as the analytic approaches evolve, it is likely that this methodology (combining 
precisely clinically phenotyped subjects with genome-wide data) will provide key information 
regarding the pathophysiology of prematurity, and provide potential new avenues for exploring 
innovative therapeutic strategies.
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1. Introduction
Approximately 12% of infants born in the USA are preterm at <37 weeks of gestation. 
Preterm infants account for >70% of the neonatal morbidity and mortality in the USA, and 
are 40 times more likely to die in the neonatal period than their term counterparts [1]. 
Despite the magnitude of this clinical problem, preterm birth (PTB) remains a clinical and 
scientific enigma. Activation of gestational tissues and eventual preterm labor with delivery 
is likely a common final pathway triggered by multiple mechanisms, including hormonal 
mediation, inflammation and infection, and genetic factors [2]. There are many steps during 
the process at which an individual’s genotype may affect phenotype in this complex and 
multistep cascade.
There is strong evidence of a genetic contribution to spontaneous PTB (sPTB). The 
strongest predictor of sPTB is a previous history of sPTB [3]. sPTB recurs in 35–50% of 
women, and tends to recur at similar gestational ages [4]. Likewise, the probability of sPTB 
increases with the number of prior sPTBs a woman has experienced, the most recent birth 
being the most predictive [5]. Women who themselves were born prematurely are at 
increased risk of sPTB [6,7]. The heritable nature of this complication is further supported 
by the findings of Winkvist and colleagues who determined that the risk of sPTB was 
elevated in women whose sisters had experienced sPTB (odds ratio: 1.94; 95% confidence 
interval: 1.26–2.99) [8]. Based on twin studies, the heritability of preterm birth is estimated 
to be 30% [9–11]. The racial disparity in the PTB rate cannot be explained by socio-
economic factors alone, suggesting differences in risk-predisposing allele frequencies [12–
16].
Numerous studies across a variety of platforms and analytic approaches have examined the 
relationship between genetics and prematurity. Unfortunately, results have often been 
inconsistent between populations and difficult to reproduce. Furthermore, though PTB is a 
multifactorial process leading to a final common pathway resulting in contractions, cervical 
dilation, and eventual delivery of the neonate, many studies of PTB have limited additional 
phenotype information, and genetic analyses are based upon relatively heterogeneous groups 
of women. Recent investigations have shown that women may be grouped into distinct PTB 
phenotypes (including infection/inflammation, decidual hemorrhage, etc.) using clinical 
information. These clinical classifications can characterize groups of women (e.g. those 
delivering very preterm), and may provide further insight beyond the heterogenous PTB 
categorization [17]. Although significant overlap between phenotypes exists, distinct 
differences have been observed between phenotypes, as those delivering at the earliest 
gestational ages and Blacks have notably different phenotypic profiles compared to others 
[17,18]. It has been hypothesized that suboptimal clinical phenotyping is a major 
contributing factor to the challenges of reproducibility that have characterized genetic 
investigations of prematurity.
The purpose of this review is to examine current investigative techniques for genetic studies, 
and to summarize current knowledge regarding the contribution of genomic studies to PTB, 
focusing on and highlighting phenotype-specific genetic investigations.
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2. Overview of genetic approaches
The study of genomic DNA allows investigators to correlate genotype with phenotype, and 
has evolved substantially over the past several decades. Traditionally, studies have used 
candidate gene approaches to evaluate whether certain alleles confer an increased or 
decreased risk of certain diseases. Candidate gene studies represent the largest body of work 
across the medical literature with regard to genetic association studies, and involve an a-
priori hypothesis regarding biologic function and genetic association. This type of study may 
be ‘hit or miss’ depending on whether the ‘right’ gene was selected by the researchers.
In contrast, examination of the entire exome or entire genome offers a more comprehensive 
and unbiased approach. High-throughput genotyping, including most genome-wide 
association study (GWAS) platforms, are now widely accessible to investigators. Although 
GWAS “scans the genome,” this technique examines only a subset of single nucleotide 
polymorphisms (SNPs) in the genome that are in linkage disequilibrium with other, non-
genotyped SNPs. Unfortunately, GWAS has little power to detect rare, potentially causal, 
genetic variants [19]. The combination of unsuccessful research attempts to find a single 
causal gene and the multifactorial nature of spontaneous PTB makes it likely that multiple 
genetic variants and gene–environment interactions that contribute to this disorder have yet 
to be elucidated. Recently, advanced technology has driven down the costs of sequencing, 
and it is now feasible for investigators to study every base pair in the human genome. The 
possibilities with regard to sequencing analyses are endless; the challenges lie in the analysis 
and interpretation of these large volumes of data [20].
Epigenetic modifications provide another mechanism by which genes may interact with the 
environment; they affect gene expression by inducing structural changes in DNA that are 
maintained through cell division, respond to changes in the environment, yet are potentially 
reversible and can be targets for disease therapy [21]. DNA methylation at cytosine–guanine 
dinucleotides (CpG sites) – the most commonly studied epigenetic modification in humans – 
guides temporal and tissue-specific gene expression during fetal development and tissue 
differentiation. Even subtle environmental changes may induce epigenetic changes and have 
effects on phenotype. Methylation is tissue specific; results from blood, placental or cervical 
tissue, for example, typically cannot be directly compared. However, methylation studies in 
blood may be a reliable correlate of physiologic processes in other tissues [22]. Methylation 
analyses can be candidate gene and very focused, or can be genome wide. Limited studies of 
epigenetics in obstetrics have demonstrated identifiable differences between women 
delivering preterm and those with term deliveries only, across a spectrum of tissue types 
(placenta, maternal blood, cord blood) [23–28]. Many PTB risk factors result in DNA 
methylation differences – for example, methylation patterns are associated with stress, diet, 
smoking, inflammatory cytokine levels, and medication exposure [29–32].
Sophisticated analysis software has become increasingly widespread for researchers to 
analyze genetic data in the framework of physiologic pathways through systems biology. 
Such programs include Ingenuity Pathway Analysis (IPA; Qiagen, Valencia, CA, USA), 
DAVID (National Institute of Allergy and Infectious Diseases, NIH), Kyoto Encyclopedia 
of Genes and Genomes (KEGG) Pathway, and others. The majority of these programs 
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function by using complex algorithms that analyze the role of a list of genes provided by the 
user, to search for connected functions and pathways, or overrepresentation of a particular 
type of gene function (e.g. genes involved in cell signaling) or ontologies.
Additional techniques not directly related to DNA are beyond the scope of this review.
A summary of example gene pathways and representative genes frequently associated with 
each main preterm birth phenotype, including preterm labor with intact membranes, is 
shown in Table 1. Each phenotype, with related genetic associations, is discussed in 
additional detail below.
3. Genetics of preterm labor with intact membranes
Although the largest number of studies has focused on “idiopathic PTB,” this phenotype is 
the most heterogeneous and should be considered a diagnosis of exclusion. In the most 
general sense, studies of spontaneous PTB often encompass those with PTB due to cervical 
insufficiency, preterm premature rupture of membranes (PPROM), placental abruption, 
uterine overdistension, or a combination of these. Women without any PTB risk factors 
frequently will have an incomplete phenotypic evaluation during pregnancy. For example, 
routine endovaginal cervical length screening is not always performed on low risk women. 
Therefore, it is possible that some women thought to have “idiopathic” PTB may indeed 
have cervical insufficiency. This may occur if a woman has a clinically unrecognized short 
cervix, which then progresses to preterm cervical dilation and eventually preterm labor. 
When the woman presents with advanced dilation, it is then impossible to discern the 
inciting event leading to the advanced preterm labor. Thus, there is considerable overlap 
between definitions of sPTB with intact membranes and PPROM, as many studies use 
different thresholds to define PPROM (minimum interval between rupture and delivery, or 
minimum interval between rupture and development of frequent uterine contractions). The 
distinction between sPTB with intact membranes and abruption is also challenging, given 
that decidual hemorrhage is a recognized risk factor for sPTB, and bloody show may be 
difficult to distinguish from an early clinical abruption. In all situations, incomplete clinical 
data collection and clinical phenotyping, particularly in the case of retrospective analyses, 
may introduce heterogeneity into the analysis and limit statistical power to detect genetic 
differences.
Nonetheless, despite these limitations, several genetic studies have been conducted using 
samples from women with clearly phenotyped PTB. These studies have most consistently 
found associations between inflammatory and coagulation gene polymorphisms and PTB 
[14,33]. Such genes include tumor necrosis factor (TNF)-α, TNF-β, interleukin (IL)-4, IL-6, 
IL-10, toll-like receptor (TLR) 2, TLR4, and nucleotide-binding oligomerization domain 
containing 2 [34]. However, even within these genes, refinement of results may be achieved 
with proper population stratification and with additional clinical phenotyping. A recent 
meta-analysis of the association between IL6 genotype and PTB within population strata 
exemplified this issue. The IL6 SNP rs1800795, genotype CC was associated with a 
decreased risk for PTB among women of European descent. This association was not 
significant among women of other ancestries [12]. Another example is the study performed 
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by Velez and colleagues, which found that IL-12 and IL-12RB polymorphisms 
(inflammatory pathway) were associated with PTB among African-American women; in 
contrast, these authors found that polymorphisms in TPA, IL10RA, FV, and FVII (both 
coagulation and inflammation pathways) to be associated with PTB among Caucasian 
women [14,33].
Recently, Capece and colleagues performed a pathway analysis of genes associated with 
sPTB with the goal of identifying maternal genetic markers for stratification of preterm birth 
due to PPROM or spontaneous PTB with intact membranes, and to differentiate between the 
mechanisms involved in these clinical endpoints. This study pooled SNP data from 
individual studies and listed all genes implicated in either sPTB or PPROM by searching for 
primary source articles as well as established genetic databases (e.g. PTB Gene: http://
ric.einstein.yu.edu/ptbgene/index.html) and then used the Ingenuity Pathway Analysis 
software to determine associations between genes on the final list. Of 185 potentially 
eligible studies, only 15 could be included in the qualitative synthesis of SNP data, including 
10 sPTB and five PPROM reports. In total, 248 SNPs in 102 genes were found to be 
statistically significantly associated (P < 0.05) with sPTB with intact membranes; these 
genes were uploaded into the IPA for network analysis. The populations were primarily 
South American, African-American, and Caucasian. The IPA revealed that the top four 
molecular and cellular functions were cell-to-cell signaling and interaction, cellular 
movement, lipid metabolism, and small molecule biochemistry, and did not differ when 
PPROM genes were analyzed. However, more detailed investigation into the pathways 
revealed that sPTB is associated with the glucocorticoid signaling pathway, inflammatory 
genes, and matrix-degrading and/or collagen metabolism-related markers [35].
There is a relative paucity of methylation studies of PTB, and most have included cohorts 
with a large amount of phenotypic heterogeneity. Furthermore, most studies have included 
samples only collected at the time of delivery; the importance of longitudinal sample 
collection should not be understated, as this has the potential to provide insight into PTB 
pathophysiology as it is evolving and also to provide the basis for the development of 
biomarkers. Parets et al. examined 40 paired maternal and cord blood samples and found 
that genes involved in metabolic, cardiovascular, and immune pathways differentially 
methylated. This study was limited to African-Americans, and the authors concluded that 
this may provide some basis for the higher rates of PTB among African-American women 
[42]. Another methylation study examined the relationship between methylation and several 
subtypes of PTB, including spontaneous preterm birth with intact membranes, PPROM, 
preterm delivery after chorioamnionitis, and medically indicated induction of labor. These 
investigators found that DNA methylation levels were increased in PLAGL1 among infants 
with chorioamnionitis (n = 10). In this cohort, no methylation changes were noted among 
infants with PTB or PPROM, but the power to detect differences was limited due to the 
sample size [43].
Several investigative teams have summarized genetic knowledge of prematurity and 
generated valuable online resources compiling these results. The ‘Database for Preterm 
Birth’ is available online at www.ptbdb.cs.brown.edu/dbPTBv1.php and allows for gene, 
SNP, and keyword searches of a curated aggregated database of prematurity genes [44].
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4. Genetics of PPROM
Numerous candidate gene studies focusing on PPROM have also been conducted. PPROM 
is the most frequently occurring specific prematurity phenotype examined after PTB with 
intact membranes has been considered. Although many have focused on inflammatory genes 
as with sPTB with intact membranes, many have also investigated genes involved with 
collagen or extracellular matrix composition. Romero and colleagues examined 225 mothers 
and 155 fetuses with PPROM and compared them to 599 mothers and 628 fetuses with 
normal pregnancies, and reported that genetic variation in the tissue inhibitor of 
metalloproteinase 2 (TIMP2) gene, alpha 3 type IV collagen isoform precursor (COL4A3), 
and a three-locus model including collagen type 1 alpha 2 (COL1A2), defensin alpha 5 
(DEFA5), and endothelin 1 (ET1) genes were associated with PPROM (approximately 
doubling the risk) [36].
In the large pathway analysis by Capece and colleagues described above, genes in 
hematologic/coagulation function disorder, collagen metabolism, matrix degradation, and 
local inflammation pathways were found in association with PPROM, which was in contrast 
to an autoimmune/hormonal regulation axis among women with PTB with intact membranes 
[35]. Furthermore, this analysis also found that although the inflammatory transcription 
factor NF-κβ is linked to both PTB with intact membranes and PPROM, the inflammatory 
response is distinctly different. Individual genes found to be associated specifically with 
PPROM included tumor necrosis factor (TNF) and nitric oxide synthase 2A (NOS2A) [35]. 
The authors also identified signal transducer and activator of transcription 1 (STAT1) as a 
PPROM-specific regulator. STAT1 is a major component of the cellular response to 
interferon-γ, regulating the immune system, cell differentiation, cell growth inhibition, and 
apoptosis [37]. It is important to note that the PPROM analyses were based primarily on 
South American (Chilean) subjects.
5. Genetics of cervical insufficiency
Cervical insufficiency is classically defined as painless mid-trimester cervical dilation 
leading to delivery. A shortened mid-trimester cervical length is now a recognized risk 
factor for spontaneous preterm birth; the shorter the cervix, the higher the risk. Cervical 
insufficiency is likely the extreme of this continuum.
Several candidate gene studies of cervical insufficiency have focused on genes involved in 
connective tissue dynamics, hypothesizing that perturbations in normal homeostasis between 
collagen, hyaluric acid, and sulfated glycosaminogylcans may influence the development of 
this clinical phenotype. Second trimester biopsy specimens from women with cervical 
insufficiency have revealed a high turnover rate of collagen with a high proportion of newly 
synthesized collagen with low biomechanical strength [38]. Thus, collagen genes are among 
the most widely investigated candidate genes among women with cervical insufficiency. 
Within the collagen 1A1 (COL1A1) gene, polymorphisms in the Sp1 binding region affect 
collagen regulation, and may lead to the formation of weaker collagen homotrimers 
compared to the normal collagen heterotrimers. SNPs within the transforming growth factor 
(TGF)-β gene also affect collagen structure by influencing the interaction between cells and 
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the extracellular matrix. Indeed, polymorphisms in COL1A1 and TGF-β genes have both 
been associated with cervical insufficiency in limited genetic association studies [39].
6. Genetics of placental abruption
Placental abruption, simply defined, is premature separation of the placenta from the uterine 
wall prior to the delivery of the fetus. Epidemiologically, it is associated with hypertensive 
disorders, advanced maternal age, cigarette smoking, illicit drug use, and external trauma to 
the abdomen. Some investigators have argued that abruption is an entity distinct from sPTB 
whereas others believe that it is an important sPTB subtype. However, like sPTB, placental 
abruption aggregates in families. Furthermore, although the diagnosis is difficult to make 
unless there is large volume blood loss, women with vaginal bleeding during pregnancy are 
known to be at high risk for preterm birth, suggesting significant overlap between the 
conditions.
The largest genetic study of abruption was the Peruvian Abruptio Placentae Epidemiology 
Study. This was a genome-wide association study of 470 placental abruption cases and 473 
controls; samples were genotyped using the Illumina Cardio-Metabochip®, and a candidate 
gene study was performed using the GWAS data focusing on genes involved with 
mitochondrial biogenesis and oxidative phosphorylation. These researchers found that genes 
known to regulate mitochondrial biogenesis and oxidative phosphorylation were associated 
with risk for placental abruption (P < 0.05) [45].
In a pilot case–control study of 233 cases and 238 controls (comprised of a subset of 
subjects from the Peruvian study), real-time quantitative polymerase chain reaction assessed 
for the relative copy number of mitochondrial DNA in maternal whole blood samples at 
delivery, and found that a trend towards an association between mitochondrial DNA copy 
number and placental abruption (among those with the highest quartile of mitochondrial 
DNA copy number, after adjusting for confounding, P = 0.09) [40]. In a GWAS study (also 
comprised of a subset of women from the Peruvian study) of abruption, no SNPs were 
significant after false discovery rate correction. However, the top hits were in the CTNNA2, 
TNFRSF1A, and ZNRF3 genes, and the top 200 SNPs from the GWAS overrepresented 
genes involved in cell cycle, growth, and proliferation [41].
7. Remaining unresolved challenges, future directions, conclusions
Even the newer pathway analyses such as the study by Capece and colleagues have relied 
upon candidate gene studies to form the foundation of their investigations. Additional high 
quality sequencing (both whole exome and whole genome) and functional genetic studies 
are urgently needed to identify new potential causative genes. As described above, only a 
limited number of studies have examined the fetal genetic contribution to prematurity. 
Genetic studies of prematurity are hampered by many challenges, including issues related to 
population stratification, population differences between different cohorts (even when 
seemingly similar race/ethnic groups are examined), and the multiple comparisons 
(particularly with small cohorts). As the cost of sequencing and functional genetic studies 
continues to decrease, these approaches will be more widely available to more investigators, 
and the analytic methods will also evolve. Clinician scientists are paying increasing attention 
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to the ever-important role of clinical phenotyping, which has the great potential to vastly 
increase the power and effectiveness of subsequent genetic association studies. Indeed, 
studies of well phenotyped individuals are promising, but must be verified in larger 
independent cohorts comprised of women from different populations. Eventually, these 
unbiased genetic association approaches will provide key information regarding the 
pathophysiology of prematurity, and will supply potential new avenues for exploring 
innovative therapeutic strategies.
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Research directions
• Refinement of clinical phenotype, followed by large genome-wide 
investigations of women meeting criteria for each phenotype.
• Investigation of the effect of fetal genotype.
• Integration of maternal and/or fetal genomic data with proteomic data.
• Expansion of analysis efforts into newer analytic techniques, including pathway 
analysis and systems biology, to understand the broader context of individual 
gene contributions to prematurity.
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Table 1
Gene pathways and representative genes frequently associated with each main preterm birth phenotype.
Phenotype Phenotype description Gene pathways or gene 
categories of interest
Example genes (official gene 
symbol)
References
Preterm labor with 
intact membranes
Most general phenotype, 
often ‘catchall’ category, 
may include women with 
incomplete phenotype 
evaluation
Inflammatory, coagulation, 
glucocorticoid signaling, 
matrix degrading and/or 
collagen metabolism-related 
markers
TNF-alpha, TNF-beta, IL4, IL6, 
IL10, IL10RA, IL12, IL12RB, 
TLR2, TLR4, NOD2, FV, FVII
[12,14,33–35]
Preterm premature 
rupture of membranes
Rupture of membranes prior 
to the onset of labor (time 
period inconsistently 
defined between studies)
Inflammatory, collagen, 
extracellular matrix, immune 
system regulation
TIMP2, COL4A3, COL1A2, 
DEFA5, ET1, NOS2A, STAT1
[35,36,37]
Cervical insufficiency Painless mid-trimester 
cervical dilation leading to 
delivery; definition now 
may include continuum of 
women with a short cervix
Connective tissue, collagen COL1A1, TGF-beta [38,39]
Placental abruption Premature separation of the 
placenta from the uterine 
wall
Mitochondrial biogenesis, 
oxidative phosphorylation, 
cell cycle, growth, and 
proliferaiton
CTNNA2, TNFRSF1A, ZNRF3 [40,41]
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